This event has an open oral and poster session. Abstracts can be submitted on any subject related to pathology
You can download the instructions for authors at
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This meeting draws together international experts to discuss current techniques and research involved in cellular and molecular pathology. This year focuses on four specific areas
- Progress in Molecular and Cellular Pathology
- Developments in Immunohistochemistry for Diagnostic Cellular Pathology
- Biomarkers
- Histopathology and Cytopathology: Advances in research and techniques
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding pathology. This meeting gathers together workings from clinical, academic and pharmaceutical organisations.
This event has CPD accreditation
Day 2: Developments in immunohistochemistry for diagnostic cellular pathology Developments in Immunohistochemistry (IHC) techniques and technology to aid the improvements needed to boost and strengthen the use of IHC in future diagnostic pathology practice will be discussed
Biomarkers identifying biological and physiological entities associated with disease are taking an increasingly important place at the tables of drug discovery and personalised medicine. Their discovery in biosamples requires the combined use of genomics, proteomics and bioinformatics platforms. Whilst for their application, robust techniques combining exquisite sensitivity and specificity must be developed. This conference is focused on technologies that are driving advances in this area and their application at gene and expression level in solid and fluid biosamples. As such this session is targeted to provide leading edge information to researchers within the academic, biotechnology and pharmaceutical sectors.
Afternoon: Histopathology and Cytopathology: Advances in research and techniques
Pediatric Liver Tumors. Pearls and Pitfalls: Professor Consolato Sergi,
Professor of Pathology and Adj. Professor of Pediatrics, University of Alberta, Canada
Update in the molecular pathology of uveal melanoma:
Professor Sarah Coupland, Professor and Honorary Consultant in Pathology, University of Liverpool, UK
Implementation of personalized medicine into clinical pathology practice
Dr Gaynae Badalian-Very, Dana Farber Cancer Institute, Harvard Medical School, USA
D-Sight, The full automated platform to analyze both nuclear and membrane Immunostaining. EGFR and Ki-67 quantification in pancreas pathologies:
Dr Niccola Funel, University of Pisa, Division of Surgical Pathology, Pisa, Italy
Emerging role of the pathologist and cancer biomarking in as applied to stratified medicine and targeted therapy: Professor Bharat Jasani, Cardiff University School of Medicine, Institute of Cancer & Genetics, UK
Quantifying digital pathology in a large human brain cohort:
Dr Atticus H Hainsworth se, Stroke & Dementia Research Centre, St George’s University of London, UK
Chromogranin A- immunoreactive cells as a biomarker in the diagnosis of irritable bowel syndrome and lymphocytic colitis: Professor Magdy El-Salhy, Stord Hospital, Dept. of Clinical Medicine, Bergen University, Norway
Application of the Nanotechnology in Immunohistochemical Staining Procedures: Dr Weiming Xu, CEO London Biotech Ltd and Department of Molecular Biology and Biotechnology, University of Sheffield, UK
Companion diagnostic tests for targeted cancer treatment: advances and challenges: Professor Yao-Shan Fan,University of Miami Miller School of Medicine, Florida, USA
Molecular expression profiles of different types of thyroid carcinomas: Dr. Monika Lamba Saini, Université catholique de Louvain, Brussels, Belgium
Diagnosing vitamin B12 deficiency using static and functional markers: Dr Agata Sobczyńska – Malefora, Viapath, St. Thomas’ Hospital, London, UK
Screening Serum Biomarkers on Cancer Patients: Using Mass Spectrometry to Answer Clinical Questions: Professor Aline M.A. Martins, Brazil
Histopathologic diagnosis in the era of new and old yeast infections in critical ill surgical patients: Assistant Professor Paola Di Carlo, Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Italy
Different pathological outcome in guinea pigs exposed to sulphur mustard and different therapeutic possibility, Professor Mohammad Hossein Boskabady, Dept. Of Physiology, School of Medicine, Mashhad University of Medical Sciences, Iran
Role of cytopathology in steering targeted therapies in lung oncology patients: Dr Harman Sekhon, University of Ottawa, Ontario, Canada
From Eustachius to Schuknecht: What have human temporal bone pathology studies taught us: Dr. Panos Dimitriadis, Luton and Dunstable Hospital, UK
MicroRNAs and the contribution of cellular pathology to understanding their role in health and disease
Dr Anthony (Tony) Warford, Senior Lecturer in Cellular Pathology, University of Westminster, UK
